查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
2000826

復健机器人市场：2026-2032年全球市场预测（按产品类型、机器人设计、目标身体部位、应用和最终用户划分）

Rehabilitation Robots Market by Product Type, Robot Design, Body Region, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，康復机器人市场价值将达到 5.7505 亿美元，到 2026 年将成长到 6.7262 亿美元，到 2032 年将达到 16.3419 亿美元，复合年增长率为 16.09%。

主要市场统计数据
基准年 2025 5.7505亿美元
预计年份：2026年 6.7262亿美元
预测年份 2032 1,634,190,000 美元
复合年增长率 (%) 16.09%

简要介绍康復机器人的现状：重点关注临床应用的驱动因素、底层技术以及向可扩展的、以患者为中心的解决方案的转变。

復健机器人技术融合了医学、工程学和人性化的设计理念，从实验室原型发展成为可用于临床、增强治疗效果的工具。过去十年间，復健机器人设备的设计已从僵硬的工业机械式结构转变为更具适应性、配备丰富感测器的系统，更加註重患者的舒适度、功能恢復以及数据驱动的个人化治疗。这项发展历程反映了嵌入式感测器、执行器小型化、材料科学以及能够解读复杂运动模式的机器学习演算法等方面的同步进步。

概述推动復健机器人领域发展的关键变革，包括人工智慧整合、分散式护理和强大的商业化方法。

在復健机器人领域，多项变革正在发生，重塑产品设计、临床应用模式和商务策略。首先，智慧技术的整合应用日益广泛。嵌入式感测器、云端分析和自适应控制演算法使设备能够学习患者特定的运动模式，并即时调整辅助力度。这种能力提高了治疗的个人化程度，并为追踪长期疗效创造了机会。

2025 年关税环境如何重塑製造和采购中復健机器人的供应链、筹资策略和经营模式。

贸易政策和关税结构的变化会对復健设备的製造商、零件供应商和下游买家产生重大影响。美国关税于2025年生效，其累积效应已在多个业务领域显现，包括零件采购、契约製造经济效益和定价策略。依赖进口执行器、高精度感测器或特种聚合物的供应商正面临投入成本上升的困境，迫使製造商重新评估其采购策略和产品架构选择。

详细的細項分析揭示了设备架构、治疗应用和最终用户环境如何共同决定临床效用和商业化路径。

细分市场层面的趋势凸显了临床需求、设备功能和护理模式的交会点如何影响产品策略和商业化进程。按设备类型划分，范围涵盖末端执行器机器人和外骨骼机器人。末端执行器机器人分为固定式（固定在固定平台上）和可穿戴式，后者能够实现更自然、更贴近任务的运动。每种设计方法都会影响临床工作流程、便携性和復原任务的针对性。外骨骼机器人分为全身型、下肢型和上肢型，这些差异导致驱动复杂性、控制方法和患者连接程序等方面的技术权衡有所不同。

深入分析人口趋势、医疗保健资金筹措模式和法规环境如何影响全球主要市场的采用趋势。

復健机器人技术的区域发展趋势反映了人口压力、医疗资金筹措模式和法规环境的差异。在美洲，人口老化、集中化的医疗网络和完善的报销体系促进了机器人疗法在住院和门诊病人中的早期应用。该地区的医疗服务提供者越来越注重营运效率和长期復健效果，而私人保险公司和公共计画则对报销机制的设计产生影响。

这篇对企业策略的深刻分析表明，临床证据、硬体和软体整合以及服务主导的经营模式如何决定竞争优势。

復健机器人领域的竞争格局由那些兼具临床可靠性、卓越工程技术和市场反应的公司主导。主要企业正大力投资于临床证据的积累，与大学附属医院和復健诊所合作，检验治疗通讯协定并展示功能性疗效。这种实证基础有助于与保险公司沟通，并为卫生经济评估提供依据，而卫生经济评估对于医院采购委员会而言正变得日益重要。

为领导者提供具体建议，以协调产品设计、证据产生和商业策略，从而加速产品普及并建立强大的业务基础。

产业领导企业可以采取以下几个切实可行的步骤来强化其策略位置，并加速在所有医疗机构中的应用。首先，优先与临床中心建立合作关係，共同製定通讯协定，并产生符合支付方要求的高品质结果数据。循证检验不仅对临床医生的接受至关重要，而且对报销谈判和采购核准也至关重要。其次，采用模组化产品架构，实现软体的迭代改进，并允许选择性地升级硬体。这有助于降低整体拥有成本 (TCO) 的担忧，并有助于建立长期的客户关係。

高度透明、多方面的调查方法结合了专家访谈、技术评估和证据的三角检验，为实际见解和分析提供了支持。

本执行摘要的调查方法整合了多方面的证据，以确保提供可靠且可操作的见解。主要研究包括对临床医生、復健专家、设备工程师和采购负责人进行结构化访谈，以收集关于可用性、临床结果和采购标准的实际观点。除这些定性资料外，还对设备架构、控制策略和材料进行了技术评估，以评估工程权衡和整合复杂性。

简明扼要的结论强调了復健机器人技术的成熟以及将技术进步转化为永续临床影响所面临的策略挑战。

復健机器人技术在感测器、驱动技术和智慧控制技术的进步推动下，正日趋成熟，成为具有重要临床意义和商业性价值的医疗技术领域。随着设备变得更加便携、可穿戴和用户友好，其应用范围正从住院患者扩展到门诊病人和家庭环境。同时，不断变化的价值链趋势和报销机制要求企业具备策略灵活性，因此，强调韧性和以结果为导向的价值提案至关重要。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 康復机器人市场：依产品类型划分

  • 治疗训练机器人
  • 辅助復健机器人
  • 外骨骼復健机器人
  • 用于评估和诊断的机器人
  • 陪伴型与社交復健机器人
  • 远距復健机器人

第九章：康復机器人市场（依机器人设计划分）

  • 外骨骼机器人
  • 末端执行器机器人
  • 软体机器人设备
  • 移动平台机器人
  • 固定式机器人工作站
  • 缆索驱动机器人系统

第十章：依身体部位分類的復健机器人市场

  • 上肢
    • 肩膀
    • 弯头
    • 手腕
    • 手和手指
  • 下肢
    • 髋关节
    • 膝盖
    • 脚踝和足部
  • 身体躯干和核心
  • 全身

第十一章 復健机器人市场：依应用领域划分

  • 老年人康復
  • 肌肉骨骼復健
  • 神经復健
  • 中风復健

第十二章 康復机器人市场：依最终用户划分

  • 居家照护
  • 医院和诊所
  • 復健中心
  • 研究机构

第十三章 康復机器人市场：按地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 康復机器人市场：依类别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 康復机器人市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国康復机器人市场

第十七章：中国康復机器人市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • AlterG, Inc.
  • Aretech, LLC
  • B-Temia Inc.
  • Bioness, Inc.
  • Bionik Laboratories Corp.
  • BioXtreme Ltd.
  • Cyberdyne Inc.
  • DIH Holding US, Inc.
  • Ekso Bionics Holdings, Inc.
  • Focal Meditech BV
  • Fourier Intelligence Group
  • GOGOA Mobility Robots, SL
  • Hocoma AG
  • Honda Motor Co., Ltd.
  • Instead Technologies, Ltd.
  • Kinova Inc.
  • KUKA AG
  • Leaders Rehab Robot
  • Life Science Robotics ApS
  • MediTouch Ltd.
  • Motorika USA Inc.
  • MRISAR
  • Myomo, Inc.
  • Ottobock SE & Co. KGaA
  • Parker-Hannifin Corporation
  • Rehab-Robotics Company Limited
  • ReWalk Robotics Ltd.
  • Rex Bionics Ltd.
  • Tyromotion GmbH
  • Vincent Medical Holdings Limited
Product Code: MRR-02026C4CB0B9

The Rehabilitation Robots Market was valued at USD 575.05 million in 2025 and is projected to grow to USD 672.62 million in 2026, with a CAGR of 16.09%, reaching USD 1,634.19 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 575.05 million
Estimated Year [2026] USD 672.62 million
Forecast Year [2032] USD 1,634.19 million
CAGR (%) 16.09%

A concise introduction to the present state of rehabilitation robotics highlighting clinical adoption drivers, enabling technologies, and the shift to scalable patient-centered solutions

Rehabilitation robotics is at the intersection of medical science, engineering, and human-centered design, evolving from laboratory prototypes into clinically deployable tools that augment therapeutic pathways. Over the past decade, devices have moved beyond rigid, industrially inspired machines to more adaptive, sensor-rich systems that prioritize patient comfort, functional outcomes, and data-driven therapy personalization. This evolution reflects parallel advances in embedded sensors, actuator miniaturization, materials science, and machine learning algorithms capable of interpreting complex movement patterns.

Clinicians and health systems are increasingly interested in technologies that can extend the reach of scarce rehabilitation expertise, support intensive repeatable therapy sessions, and objectively measure progress. However, adoption is mediated by factors such as ease of integration into clinical workflows, the evidence base demonstrating functional gains, reimbursement frameworks, and device ergonomics. As a result, successful devices combine validated therapeutic protocols with intuitive user interfaces and robust safety features.

Looking ahead, the field is defined by a pragmatic shift: from proof-of-concept demonstrations toward scalable solutions that deliver measurable clinical value across inpatient, outpatient, and home-based settings. This transition is powered by cross-disciplinary collaboration among clinicians, engineers, and data scientists, and is supported by a maturing ecosystem of component suppliers, service partners, and regulatory pathways that together enable responsible clinical deployment.

An overview of the major transformative shifts driving the rehabilitation robotics landscape including AI integration, care decentralization, and resilient commercialization approaches

The rehabilitation robotics landscape is undergoing several transformative shifts that are reshaping product design, clinical use models, and business strategies. First, intelligence infusion is pervasive: embedded sensors, cloud-connected analytics, and adaptive control algorithms now enable devices to learn from patient-specific movement patterns and to modulate assistance in real time. This capability improves therapy personalization and creates opportunities for longitudinal outcome tracking.

Second, the locus of care is expanding beyond hospital walls into community clinics and the home. Advances in portability, battery technology, and simplified donning/dof mechanisms are enabling devices that clinicians and patients can use outside of supervised laboratory settings. Consequently, reimbursement and care-delivery models are adapting to emphasize remote monitoring, tele-rehabilitation support, and outcome-based payment arrangements.

Third, human factors and soft robotics are gaining prominence, with designers focusing on comfort, wearability, and naturalistic movement assistance rather than brute-force actuation. This emphasis reduces patient fatigue and improves adherence, particularly among geriatric and neurologic populations. In parallel, modular architectures that support hardware-software co-evolution are becoming common, allowing manufacturers to deploy iterative performance improvements without wholesale hardware replacement.

Finally, supply chain resilience and regulatory alignment are emerging as strategic imperatives. Manufacturers are investing in diversified sourcing, localized assembly, and stronger post-market surveillance capabilities to meet stringent safety expectations and to shorten time-to-clinical-deployment. Collectively, these shifts are converging to make rehabilitation robots more clinically relevant, commercially viable, and accessible across a broader range of care settings.

How the 2025 tariff environment reshaped supply chains, sourcing strategies, and commercial models for rehabilitation robotics across manufacturing and procurement

Changes in trade policy and tariff structures can materially affect manufacturers, component suppliers, and downstream purchasers of rehabilitation devices. The cumulative impact of United States tariffs enacted in 2025 has manifested across multiple operational vectors, including component sourcing, contract manufacturing economics, and pricing strategies. Suppliers reliant on imported actuators, precision sensors, or specialized polymers have faced increased input costs, which in turn pressured manufacturers to reassess sourcing footprints and product architecture choices.

In response to tariff-driven cost pressures, several original equipment manufacturers accelerated localization initiatives and strategic supplier diversification to mitigate exposure. These adjustments have included qualifying alternative vendors, redesigning assemblies to use more readily available components, and selectively onshoring higher-value production steps where labor and capital economics permitted. Such strategies helped preserve product performance while reducing vulnerability to trade policy volatility.

Procurement practices among large healthcare systems also shifted, as purchasing teams weighed total cost of ownership against device performance and support capabilities. Longer-term service agreements and multi-year maintenance contracts gained traction as ways to stabilize operating expenses despite unit price pressures. At the same time, some small and mid-sized suppliers encountered tighter margins, prompting consolidation activity and renewed focus on niche clinical applications where differentiated technology commands stronger pricing power.

From an innovation perspective, tariff-induced constraints spurred renewed emphasis on software-centric value propositions. Companies leaned into cloud analytics, remote therapy modules, and subscription-based service models to offset hardware cost headwinds. In short, the 2025 tariff environment accelerated structural changes in supply chains and commercial models, prompting a rebalancing toward resilience, modularity, and service-led differentiation.

Deep segmentation insights revealing how device architecture, therapeutic application, and end-user settings jointly determine clinical utility and commercialization pathways

Segment-level dynamics underscore where clinical need, device capability, and care delivery intersect to shape product strategy and commercialization. Based on device type, the universe includes End Effector Robots and Exoskeleton Robots. End Effector Robots are differentiated by stationary designs that anchor to a fixed platform and wearable variants that enable more natural, task-oriented exercises; each design path influences clinical workflows, portability, and rehabilitation task specificity. Exoskeleton Robots split into Full Body, Lower Limb, and Upper Limb categories, and these distinctions drive divergent engineering trade-offs in actuation complexity, control schemes, and patient fitting procedures.

Application-driven segmentation highlights therapeutic indications such as Geriatric Rehabilitation, Musculoskeletal Rehabilitation, Neurological Rehabilitation, and Stroke Rehabilitation. Devices tailored for geriatric rehabilitation prioritize safety, ease of use, and fall-mitigation features, while musculoskeletal solutions emphasize joint-level assistance and strength retraining. Neurological and stroke-focused technologies demand finer-grained control, adaptive assistance profiles, and validated outcome measures to support neuroplasticity-driven recovery.

End-user segmentation captures the diversity of deployment environments, spanning Home Care, Hospitals and Clinics, Rehabilitation Centers, and Research Institutes. Home care deployments require simplified setup, remote monitoring, and robust customer support. Hospitals and clinics demand seamless integration with existing therapy workflows and stringent infection control features. Rehabilitation centers favor devices that enable high-intensity, specialized protocols, and research institutes prioritize modularity and data access for experimental protocols. Understanding how device types map to applications and end users is essential for designing commercially viable propositions that align with clinical pathways and procurement norms.

Key regional insights into how demographic trends, healthcare funding models, and regulatory environments shape adoption trajectories across major global markets

Regional dynamics for rehabilitation robotics reflect differing demographic pressures, healthcare financing models, and regulatory environments. In the Americas, aging populations, concentrated healthcare networks, and established reimbursement systems have supported early adoption of both inpatient and outpatient robotic therapies. Healthcare providers in this region increasingly evaluate device investments against operational efficiencies and long-term rehabilitative outcomes, while private payers and public programs influence reimbursement design.

Europe, Middle East & Africa present a heterogeneous landscape where national regulatory frameworks, public healthcare funding, and clinical practice patterns vary widely. Western European health systems often emphasize evidence generation and cost-effectiveness studies, encouraging solutions that demonstrate clear functional gains. Meanwhile, some Middle Eastern and African markets prioritize acute care capabilities and may adopt innovative devices through centers of excellence or private specialty clinics, creating pockets of concentrated demand.

Asia-Pacific is characterized by rapid demographic shifts, expanding middle-class healthcare consumption, and strong government-led initiatives to modernize rehabilitation infrastructure. Several countries in the region are investing in digital health platforms and home-based care models, which create fertile conditions for wearable rehabilitation devices and remote therapy services. Across all regions, regulatory harmonization efforts and international clinical collaborations are smoothing pathways for cross-border device approval and multinational clinical trials, thereby accelerating global diffusion of validated solutions.

Insightful analysis of company strategies showing how clinical evidence, hardware-software integration, and service-led commercial models define competitive advantage

Competitive dynamics in rehabilitation robotics are defined by firms that combine clinical credibility with engineering excellence and go-to-market agility. Leading organizations invest heavily in clinical evidence generation, partnering with academic medical centers and rehabilitation clinics to validate therapeutic protocols and demonstrate functional outcomes. This evidence base supports engagement with payers and informs health economic assessments that are increasingly essential for hospital procurement committees.

Product strategies vary across the value chain. Some companies prioritize hardware differentiation-developing proprietary actuation systems, lightweight materials, and advanced sensing suites-while others focus on software ecosystems that enable remote monitoring, adaptive training programs, and clinician dashboards. A growing number of vendors emphasize interoperable platforms that can be upgraded via software, reducing the need for frequent hardware revisions and extending product lifecycles.

Commercially, successful firms blend direct clinical sales with channel partnerships and service-oriented revenue streams. They bolster adoption through training programs, clinician education, and outcomes-driven support offerings. Strategic alliances with component suppliers, contract manufacturers, and rehabilitation service providers also play an important role in scaling operations and accelerating geographic expansion. Overall, the competitive landscape rewards organizations that can demonstrate therapeutic benefit, deliver seamless clinical integration, and sustain post-sale support.

Actionable recommendations for leaders to align product design, evidence generation, and commercial strategies to accelerate adoption and build resilient operations

Industry leaders can take several practical actions to strengthen their strategic position and accelerate adoption across care settings. First, prioritize partnerships with clinical centers to co-develop protocols and generate high-quality outcome data that align with payer requirements. Evidence-based validation is critical not only for clinician acceptance but also for reimbursement discussions and procurement approvals. Second, pursue modular product architectures that enable iterative software improvements and allow selective hardware upgrades; this reduces total cost of ownership concerns and supports longer customer relationships.

Third, invest in supply-chain resilience by diversifying suppliers, qualifying secondary vendors, and considering localized assembly for critical subassemblies. Such measures mitigate trade-policy and logistics risks while improving lead-time predictability. Fourth, focus on the end-user experience-simplifying device setup, enhancing wearability, and designing clinician-facing interfaces that integrate with electronic health records-to lower barriers to clinical adoption and increase patient adherence.

Finally, develop hybrid commercial models that combine device sales with subscription-based services for analytics, clinician training, and remote monitoring. This approach creates recurring revenue, deepens customer relationships, and reinforces the clinical value proposition through continuous performance feedback. Taken together, these actions can help organizations navigate regulatory complexity, align with evolving care delivery models, and build sustainable competitive differentiation.

A transparent multi-method research methodology combining expert interviews, technical assessments, and evidence triangulation to underpin actionable insights and analysis

The research methodology underpinning this executive summary integrates multiple evidence streams to ensure robust, actionable insights. Primary research included structured interviews with clinicians, rehabilitation specialists, device engineers, and procurement professionals to capture frontline perspectives on usability, clinical outcomes, and purchasing criteria. These qualitative inputs were complemented by technical assessments of device architectures, control strategies, and materials to evaluate engineering trade-offs and integration complexity.

Secondary research drew on peer-reviewed clinical literature, regulatory filings, and publicly available technical specifications to triangulate claims about device performance and therapeutic mechanisms. Trade publications and conference proceedings provided contemporary examples of pilot deployments and early-stage clinical results. Data synthesis emphasized cross-validation among sources and critical appraisal of evidence quality.

Analytical rigor was maintained through a transparent triangulation process that reconciled qualitative insights with technical documentation and regulatory information. Limitations were explicitly acknowledged, including variability in clinical study designs and heterogeneity in deployment contexts. Where evidence gaps existed, recommendations were cautiously framed to reflect the range of plausible outcomes rather than definitive forecasts. This methodology ensures that conclusions are grounded in current practice and that strategic guidance remains practical for decision-makers.

A concise conclusion emphasizing the maturation of rehabilitation robotics and the strategic imperatives for translating technological advances into sustained clinical impact

Rehabilitation robotics is maturing into a clinically relevant and commercially viable segment of healthcare technology, driven by converging advances in sensors, actuation, and intelligent control. Adoption is expanding across inpatient, outpatient, and home settings as devices become more portable, wearable, and user-friendly. At the same time, supply-chain dynamics and evolving reimbursement frameworks require companies to be strategically nimble, emphasizing resilience and outcome-oriented value propositions.

Success in this evolving landscape depends on combining rigorous clinical validation with modular product design and robust commercial support. Firms that demonstrate clear therapeutic benefits, simplify clinical integration, and offer service-led business models will be well positioned to capture long-term adoption opportunities. Additionally, regional nuances in regulation, reimbursement, and care delivery will continue to influence deployment priorities and the pace of integration.

In sum, rehabilitation robotics stands at a pivotal moment where technological capability can translate into meaningful patient outcomes and new care paradigms, provided that stakeholders align around evidence generation, patient-centric design, and sustainable commercialization strategies.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Rehabilitation Robots Market, by Product Type

  • 8.1. Therapeutic Training Robots
  • 8.2. Assistive Rehabilitation Robots
  • 8.3. Exoskeleton Rehabilitation Robots
  • 8.4. Assessment And Diagnostic Robots
  • 8.5. Companion And Social Rehabilitation Robots
  • 8.6. Tele-Rehabilitation Robots

9. Rehabilitation Robots Market, by Robot Design

  • 9.1. Exoskeleton Robots
  • 9.2. End-Effector Robots
  • 9.3. Soft Robotics Devices
  • 9.4. Mobile Platform Robots
  • 9.5. Stationary Robotic Workstations
  • 9.6. Cable-Driven Robotic Systems

10. Rehabilitation Robots Market, by Body Region

  • 10.1. Upper Limb
    • 10.1.1. Shoulder
    • 10.1.2. Elbow
    • 10.1.3. Wrist
    • 10.1.4. Hand And Fingers
  • 10.2. Lower Limb
    • 10.2.1. Hip
    • 10.2.2. Knee
    • 10.2.3. Ankle And Foot
  • 10.3. Trunk And Core
  • 10.4. Full Body

11. Rehabilitation Robots Market, by Application

  • 11.1. Geriatric Rehabilitation
  • 11.2. Musculoskeletal Rehabilitation
  • 11.3. Neurological Rehabilitation
  • 11.4. Stroke Rehabilitation

12. Rehabilitation Robots Market, by End User

  • 12.1. Home Care
  • 12.2. Hospitals Clinics
  • 12.3. Rehabilitation Centers
  • 12.4. Research Institutes

13. Rehabilitation Robots Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Rehabilitation Robots Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Rehabilitation Robots Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Rehabilitation Robots Market

17. China Rehabilitation Robots Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. AlterG, Inc.
  • 18.6. Aretech, LLC
  • 18.7. B-Temia Inc.
  • 18.8. Bioness, Inc.
  • 18.9. Bionik Laboratories Corp.
  • 18.10. BioXtreme Ltd.
  • 18.11. Cyberdyne Inc.
  • 18.12. DIH Holding US, Inc.
  • 18.13. Ekso Bionics Holdings, Inc.
  • 18.14. Focal Meditech BV
  • 18.15. Fourier Intelligence Group
  • 18.16. GOGOA Mobility Robots, SL
  • 18.17. Hocoma AG
  • 18.18. Honda Motor Co., Ltd.
  • 18.19. Instead Technologies, Ltd.
  • 18.20. Kinova Inc.
  • 18.21. KUKA AG
  • 18.22. Leaders Rehab Robot
  • 18.23. Life Science Robotics ApS
  • 18.24. MediTouch Ltd.
  • 18.25. Motorika USA Inc.
  • 18.26. MRISAR
  • 18.27. Myomo, Inc.
  • 18.28. Ottobock SE & Co. KGaA
  • 18.29. Parker-Hannifin Corporation
  • 18.30. Rehab-Robotics Company Limited
  • 18.31. ReWalk Robotics Ltd.
  • 18.32. Rex Bionics Ltd.
  • 18.33. Tyromotion GmbH
  • 18.34. Vincent Medical Holdings Limited

LIST OF FIGURES

  • FIGURE 1. GLOBAL REHABILITATION ROBOTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL REHABILITATION ROBOTS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL REHABILITATION ROBOTS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY ROBOT DESIGN, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY BODY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES REHABILITATION ROBOTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA REHABILITATION ROBOTS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL REHABILITATION ROBOTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY THERAPEUTIC TRAINING ROBOTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY THERAPEUTIC TRAINING ROBOTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY THERAPEUTIC TRAINING ROBOTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY ASSISTIVE REHABILITATION ROBOTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY ASSISTIVE REHABILITATION ROBOTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY ASSISTIVE REHABILITATION ROBOTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY EXOSKELETON REHABILITATION ROBOTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY EXOSKELETON REHABILITATION ROBOTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY EXOSKELETON REHABILITATION ROBOTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY ASSESSMENT AND DIAGNOSTIC ROBOTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY ASSESSMENT AND DIAGNOSTIC ROBOTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY ASSESSMENT AND DIAGNOSTIC ROBOTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY COMPANION AND SOCIAL REHABILITATION ROBOTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY COMPANION AND SOCIAL REHABILITATION ROBOTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY COMPANION AND SOCIAL REHABILITATION ROBOTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY TELE-REHABILITATION ROBOTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY TELE-REHABILITATION ROBOTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY TELE-REHABILITATION ROBOTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY ROBOT DESIGN, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY EXOSKELETON ROBOTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY EXOSKELETON ROBOTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY EXOSKELETON ROBOTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY END-EFFECTOR ROBOTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY END-EFFECTOR ROBOTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY END-EFFECTOR ROBOTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY SOFT ROBOTICS DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY SOFT ROBOTICS DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY SOFT ROBOTICS DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY MOBILE PLATFORM ROBOTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY MOBILE PLATFORM ROBOTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY MOBILE PLATFORM ROBOTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY STATIONARY ROBOTIC WORKSTATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY STATIONARY ROBOTIC WORKSTATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY STATIONARY ROBOTIC WORKSTATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY CABLE-DRIVEN ROBOTIC SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY CABLE-DRIVEN ROBOTIC SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY CABLE-DRIVEN ROBOTIC SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY BODY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY UPPER LIMB, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY UPPER LIMB, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY UPPER LIMB, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY UPPER LIMB, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY SHOULDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY SHOULDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY SHOULDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY ELBOW, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY ELBOW, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY ELBOW, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY WRIST, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY WRIST, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY WRIST, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY HAND AND FINGERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY HAND AND FINGERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY HAND AND FINGERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY LOWER LIMB, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY LOWER LIMB, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY LOWER LIMB, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY LOWER LIMB, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY HIP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY HIP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY HIP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY KNEE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY KNEE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY KNEE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY ANKLE AND FOOT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY ANKLE AND FOOT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY ANKLE AND FOOT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY TRUNK AND CORE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY TRUNK AND CORE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY TRUNK AND CORE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY FULL BODY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY FULL BODY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY FULL BODY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY GERIATRIC REHABILITATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY GERIATRIC REHABILITATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY GERIATRIC REHABILITATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY MUSCULOSKELETAL REHABILITATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY MUSCULOSKELETAL REHABILITATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY MUSCULOSKELETAL REHABILITATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY NEUROLOGICAL REHABILITATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY NEUROLOGICAL REHABILITATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY NEUROLOGICAL REHABILITATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY STROKE REHABILITATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY STROKE REHABILITATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY STROKE REHABILITATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY HOSPITALS CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY HOSPITALS CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY HOSPITALS CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY REHABILITATION CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY REHABILITATION CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY REHABILITATION CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS REHABILITATION ROBOTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS REHABILITATION ROBOTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS REHABILITATION ROBOTS MARKET SIZE, BY ROBOT DESIGN, 2018-2032 (USD MILLION)
  • TABLE 106. AMERICAS REHABILITATION ROBOTS MARKET SIZE, BY BODY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. AMERICAS REHABILITATION ROBOTS MARKET SIZE, BY UPPER LIMB, 2018-2032 (USD MILLION)
  • TABLE 108. AMERICAS REHABILITATION ROBOTS MARKET SIZE, BY LOWER LIMB, 2018-2032 (USD MILLION)
  • TABLE 109. AMERICAS REHABILITATION ROBOTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 110. AMERICAS REHABILITATION ROBOTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA REHABILITATION ROBOTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA REHABILITATION ROBOTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA REHABILITATION ROBOTS MARKET SIZE, BY ROBOT DESIGN, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA REHABILITATION ROBOTS MARKET SIZE, BY BODY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA REHABILITATION ROBOTS MARKET SIZE, BY UPPER LIMB, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA REHABILITATION ROBOTS MARKET SIZE, BY LOWER LIMB, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA REHABILITATION ROBOTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA REHABILITATION ROBOTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA REHABILITATION ROBOTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA REHABILITATION ROBOTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA REHABILITATION ROBOTS MARKET SIZE, BY ROBOT DESIGN, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA REHABILITATION ROBOTS MARKET SIZE, BY BODY REGION, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA REHABILITATION ROBOTS MARKET SIZE, BY UPPER LIMB, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA REHABILITATION ROBOTS MARKET SIZE, BY LOWER LIMB, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA REHABILITATION ROBOTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA REHABILITATION ROBOTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA REHABILITATION ROBOTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA REHABILITATION ROBOTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA REHABILITATION ROBOTS MARKET SIZE, BY ROBOT DESIGN, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA REHABILITATION ROBOTS MARKET SIZE, BY BODY REGION, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA REHABILITATION ROBOTS MARKET SIZE, BY UPPER LIMB, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA REHABILITATION ROBOTS MARKET SIZE, BY LOWER LIMB, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA REHABILITATION ROBOTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA REHABILITATION ROBOTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE REHABILITATION ROBOTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE REHABILITATION ROBOTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE REHABILITATION ROBOTS MARKET SIZE, BY ROBOT DESIGN, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE REHABILITATION ROBOTS MARKET SIZE, BY BODY REGION, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE REHABILITATION ROBOTS MARKET SIZE, BY UPPER LIMB, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE REHABILITATION ROBOTS MARKET SIZE, BY LOWER LIMB, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE REHABILITATION ROBOTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE REHABILITATION ROBOTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST REHABILITATION ROBOTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST REHABILITATION ROBOTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST REHABILITATION ROBOTS MARKET SIZE, BY ROBOT DESIGN, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST REHABILITATION ROBOTS MARKET SIZE, BY BODY REGION, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST REHABILITATION ROBOTS MARKET SIZE, BY UPPER LIMB, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST REHABILITATION ROBOTS MARKET SIZE, BY LOWER LIMB, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST REHABILITATION ROBOTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST REHABILITATION ROBOTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. AFRICA REHABILITATION ROBOTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 152. AFRICA REHABILITATION ROBOTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. AFRICA REHABILITATION ROBOTS MARKET SIZE, BY ROBOT DESIGN, 2018-2032 (USD MILLION)
  • TABLE 154. AFRICA REHABILITATION ROBOTS MARKET SIZE, BY BODY REGION, 2018-2032 (USD MILLION)
  • TABLE 155. AFRICA REHABILITATION ROBOTS MARKET SIZE, BY UPPER LIMB, 2018-2032 (USD MILLION)
  • TABLE 156. AFRICA REHABILITATION ROBOTS MARKET SIZE, BY LOWER LIMB, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA REHABILITATION ROBOTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA REHABILITATION ROBOTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC REHABILITATION ROBOTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC REHABILITATION ROBOTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC REHABILITATION ROBOTS MARKET SIZE, BY ROBOT DESIGN, 2018-2032 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC REHABILITATION ROBOTS MARKET SIZE, BY BODY REGION, 2018-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC REHABILITATION ROBOTS MARKET SIZE, BY UPPER LIMB, 2018-2032 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC REHABILITATION ROBOTS MARKET SIZE, BY LOWER LIMB, 2018-2032 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC REHABILITATION ROBOTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC REHABILITATION ROBOTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 168. ASEAN REHABILITATION ROBOTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. ASEAN REHABILITATION ROBOTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. ASEAN REHABILITATION ROBOTS MARKET SIZE, BY ROBOT DESIGN, 2018-2032 (USD MILLION)
  • TABLE 171. ASEAN REHABILITATION ROBOTS MARKET SIZE, BY BODY REGION, 2018-2032 (USD MILLION)
  • TABLE 172. ASEAN REHABILITATION ROBOTS MARKET SIZE, BY UPPER LIMB, 2018-2032 (USD MILLION)
  • TABLE 173. ASEAN REHABILITATION ROBOTS MARKET SIZE, BY LOWER LIMB, 2018-2032 (USD MILLION)
  • TABLE 174. ASEAN REHABILITATION ROBOTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 175. ASEAN REHABILITATION ROBOTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 176. GCC REHABILITATION ROBOTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 177. GCC REHABILITATION ROBOTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. GCC REHABILITATION ROBOTS MARKET SIZE, BY ROBOT DESIGN, 2018-2032 (USD MILLION)
  • TABLE 179. GCC REHABILITATION ROBOTS MARKET SIZE, BY BODY REGION, 2018-2032 (USD MILLION)
  • TABLE 180. GCC REHABILITATION ROBOTS MARKET SIZE, BY UPPER LIMB, 2018-2032 (USD MILLION)
  • TABLE 181. GCC REHABILITATION ROBOTS MARKET SIZE, BY LOWER LIMB, 2018-2032 (USD MILLION)
  • TABLE 182. GCC REHABILITATION ROBOTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 183. GCC REHABILITATION ROBOTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPEAN UNION REHABILITATION ROBOTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPEAN UNION REHABILITATION ROBOTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPEAN UNION REHABILITATION ROBOTS MARKET SIZE, BY ROBOT DESIGN, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPEAN UNION REHABILITATION ROBOTS MARKET SIZE, BY BODY REGION, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPEAN UNION REHABILITATION ROBOTS MARKET SIZE, BY UPPER LIMB, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPEAN UNION REHABILITATION ROBOTS MARKET SIZE, BY LOWER LIMB, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPEAN UNION REHABILITATION ROBOTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPEAN UNION REHABILITATION ROBOTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 192. BRICS REHABILITATION ROBOTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. BRICS REHABILITATION ROBOTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. BRICS REHABILITATION ROBOTS MARKET SIZE, BY ROBOT DESIGN, 2018-2032 (USD MILLION)
  • TABLE 195. BRICS REHABILITATION ROBOTS MARKET SIZE, BY BODY REGION, 2018-2032 (USD MILLION)
  • TABLE 196. BRICS REHABILITATION ROBOTS MARKET SIZE, BY UPPER LIMB, 2018-2032 (USD MILLION)
  • TABLE 197. BRICS REHABILITATION ROBOTS MARKET SIZE, BY LOWER LIMB, 2018-2032 (USD MILLION)
  • TABLE 198. BRICS REHABILITATION ROBOTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 199. BRICS REHABILITATION ROBOTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. G7 REHABILITATION ROBOTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 201. G7 REHABILITATION ROBOTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. G7 REHABILITATION ROBOTS MARKET SIZE, BY ROBOT DESIGN, 2018-2032 (USD MILLION)
  • TABLE 203. G7 REHABILITATION ROBOTS MARKET SIZE, BY BODY REGION, 2018-2032 (USD MILLION)
  • TABLE 204. G7 REHABILITATION ROBOTS MARKET SIZE, BY UPPER LIMB, 2018-2032 (USD MILLION)
  • TABLE 205. G7 REHABILITATION ROBOTS MARKET SIZE, BY LOWER LIMB, 2018-2032 (USD MILLION)
  • TABLE 206. G7 REHABILITATION ROBOTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 207. G7 REHABILITATION ROBOTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 208. NATO REHABILITATION ROBOTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 209. NATO REHABILITATION ROBOTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. NATO REHABILITATION ROBOTS MARKET SIZE, BY ROBOT DESIGN, 2018-2032 (USD MILLION)
  • TABLE 211. NATO REHABILITATION ROBOTS MARKET SIZE, BY BODY REGION, 2018-2032 (USD MILLION)
  • TABLE 212. NATO REHABILITATION ROBOTS MARKET SIZE, BY UPPER LIMB, 2018-2032 (USD MILLION)
  • TABLE 213. NATO REHABILITATION ROBOTS MARKET SIZE, BY LOWER LIMB, 2018-2032 (USD MILLION)
  • TABLE 214. NATO REHABILITATION ROBOTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 215. NATO REHABILITATION ROBOTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 216. GLOBAL REHABILITATION ROBOTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 217. UNITED STATES REHABILITATION ROBOTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 218. UNITED STATES REHABILITATION ROBOTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. UNITED STATES REHABILITATION ROBOTS MARKET SIZE, BY ROBOT DESIGN, 2018-2032 (USD MILLION)
  • TABLE 220. UNITED STATES REHABILITATION ROBOTS MARKET SIZE, BY BODY REGION, 2018-2032 (USD MILLION)
  • TABLE 221. UNITED STATES REHABILITATION ROBOTS MARKET SIZE, BY UPPER LIMB, 2018-2032 (USD MILLION)
  • TABLE 222. UNITED STATES REHABILITATION ROBOTS MARKET SIZE, BY LOWER LIMB, 2018-2032 (USD MILLION)
  • TABLE 223. UNITED STATES REHABILITATION ROBOTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 224. UNITED STATES REHABILITATION ROBOTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 225. CHINA REHABILITATION ROBOTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 226. CHINA REHABILITATION ROBOTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 227. CHINA REHABILITATION ROBOTS MARKET SIZE, BY ROBOT DESIGN, 2018-2032 (USD MILLION)
  • TABLE 228. CHINA REHABILITATION ROBOTS MARKET SIZE, BY BODY REGION, 2018-2032 (USD MILLION)
  • TABLE 229. CHINA REHABILITATION ROBOTS MARKET SIZE, BY UPPER LIMB, 2018-2032 (USD MILLION)
  • TABLE 230. CHINA REHABILITATION ROBOTS MARKET SIZE, BY LOWER LIMB, 2018-2032 (USD MILLION)
  • TABLE 231. CHINA REHABILITATION ROBOTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 232. CHINA REHABILITATION ROBOTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)